Welcome to our dedicated page for The Beauty Health Company news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on The Beauty Health Company stock.
The Beauty Health Company (NASDAQ: SKIN) generates a steady flow of news at the intersection of medical technology, professional aesthetics, and beauty. As the parent of Hydrafacial, SkinStylus, and Keravive, the company issues regular updates on financial performance, science-backed innovation, provider partnerships, and corporate governance, giving investors and industry followers insight into how its skin health platform is evolving.
On this page, readers can follow earnings announcements and financial results, where BeautyHealth reports net sales, gross margin, adjusted EBITDA, delivery systems sold, and active install base across the Americas, Asia-Pacific, and EMEA. These releases often include management commentary on trends in device sales versus consumables, the performance of the recurring revenue stream, and changes in regional go-to-market strategies.
News coverage also highlights product and innovation updates, such as the launch of boosters like HydraFillic with Pep9 and references to Hydralock HA Booster, as well as insights from the company’s Skintuition Report, which explores consumer trends in modern skin health and aesthetics. Additional stories focus on initiatives like the Hydrafacial Advisory Councils and Ambassador Network, which bring together plastic surgeons, dermatologists, aesthetic practitioners, and estheticians to guide product development, education, and clinical research.
Corporate and governance news includes executive appointments, board changes, and capital structure developments, such as the appointment of a new President and Chief Executive Officer, the addition of a new independent director, and updates related to convertible senior notes and charter amendments. For anyone tracking SKIN, this news feed offers a centralized view of the company’s operational progress, strategic priorities, and role in professional skin and scalp health.
The Beauty Health Company (NASDAQ:SKIN) has announced that it will release its fourth quarter and full-year fiscal 2022 results on February 28, 2023, before market opening. Following the release, the company will host an investor conference call at 8:30 a.m. Eastern Time. Investors and analysts can participate via a webcast available on their investor relations website. Beauty Health, known for its flagship brand Hydrafacial, provides innovative skincare solutions globally, available in over 90 countries with nearly 25,000 delivery systems.
The Beauty Health Company (NASDAQ: SKIN) announced that its Hydrafacial treatment significantly improves acne concerns, as per a study published in the Journal of Clinical and Aesthetic Dermatology. All study participants, aged 19 to 48, noted clearer, less inflamed skin following a series of treatments every two weeks over 12 weeks. Participants reported improved acne severity and a boost in self-confidence, with 100% feeling more confident by the study's end. The findings aim to encourage those suffering from acne to consider Hydrafacial's clarifying treatment.
The Beauty Health Company (NASDAQ:SKIN) has launched a new hydration booster in collaboration with BABOR Skincare, the DOCTOR BABOR Collagen HA booster. This product utilizes advanced formulations featuring collagen peptides and hyaluronic acid to enhance skin hydration and elasticity. The booster is designed to be used with Hydrafacial's patented delivery system, offering customization for various skin concerns. The product is now available across North America, expanding Hydrafacial's lineup of over 20 customizable boosters.
The Beauty Health Company (NASDAQ: SKIN) announced that CEO Andrew Stanleick and CFO Liyuan Woo will participate in a fireside chat at the Stifel 2022 Healthcare Conference on November 15, 2022, at 9:10 a.m. ET in New York, NY. The discussion will be available via live webcast on the company’s investor relations website, with an archived replay and transcript accessible after the event. Beauty Health focuses on innovative beauty health experiences through its flagship brand, HydraFacial, which operates in over 90 countries with nearly 25,000 delivery systems.
The Beauty Health Company (NASDAQ: SKIN) has announced a $100 million accelerated share repurchase (ASR) agreement with JP Morgan Chase Bank. This buyback follows a prior repurchase program initiated on September 27, 2022, with $100 million remaining as of November 9, 2022. Under the ASR, Beauty Health expects to receive approximately 9.5 million shares on November 14, 2022. The company will fund the repurchase using available cash and anticipates a strong financial position post-buyback, reinforcing confidence in its business growth and infrastructure investments.
The Beauty Health Company (NASDAQ: SKIN) reported third-quarter net sales of $88.8 million, marking a 30% year-over-year growth and exceeding expectations for the seventh consecutive quarter. The company raised its fiscal 2022 net sales guidance to $360-$365 million. Adjusted EBITDA for the quarter was $16.5 million, up from $5.8 million in Q3 2021. However, it revised its full-year adjusted EBITDA guidance down to $45-$50 million due to macroeconomic pressures, including foreign exchange impacts and China's zero-COVID policy.
The Beauty Health Company (NASDAQ:SKIN) has announced a partnership with Dr. Dennis Gross Skincare to develop a new booster for Hydrafacial treatments. This collaboration aims to blend Dr. Gross’s skincare technology with Hydrafacial’s Vortex Fusion technology, enhancing treatment customization. The new booster is expected to be available in 2023 and is part of a broader strategy to quickly respond to consumer trends. BeautyHealth CEO Andrew Stanleick highlighted the innovative nature of their booster strategy, positioning it as a key differentiator in the beauty industry.
The Beauty Health Company (NASDAQ:SKIN) announced the launch of a new exfoliating product, the Glytone AHA Resurfacing Cellular Booster, co-created with Glytone. This new booster will be available at U.S. providers starting November 9. It features three alpha hydroxy acids designed to enhance skin texture and achieve a radiant complexion. The product is compatible with Hydrafacial’s patented technology, targeting consumers with sensitive skin. The collaboration emphasizes both brands' commitment to dermatological science and personalized skincare solutions.
Beauty Health Company (NASDAQ: SKIN) has appointed David Aquino as Executive Vice President, Global Operations. This new role is crucial for enhancing the company's global supply chain, quality, distribution, and logistics. David's expertise, particularly from his time at Kindthread and SharkNinja, is expected to accelerate BeautyHealth's growth phase. The company aims to optimize infrastructure to capitalize on opportunities in the beauty health market. This appointment aligns with their strategy to double business size and triple adjusted EBITDA by 2025.
The Beauty Health Company (NASDAQ:SKIN) will report its third quarter 2022 financial results before market open on November 8, 2022. Following this, an investor conference call will take place at 8:30 a.m. Eastern Time. Investors and analysts can access the call via webcast. The company, known for its Hydrafacial brand, continues to expand its presence globally with nearly 23,000 delivery systems operational in over 90 countries.